156 related articles for article (PubMed ID: 34876845)
1. Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of
Lin T; Zhang E; Lin Z; Peng L
Int J Gen Med; 2021; 14():9117-9130. PubMed ID: 34876845
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma.
Lu Y; Liang H; Li X; Chen H; Yang C
Aging (Albany NY); 2023 May; 15(11):4699-4713. PubMed ID: 37294538
[TBL] [Abstract][Full Text] [Related]
3. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Li L; Wang X; Ding Y; Hui N; Su B; Yang M
Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
5.
Lin T; Zhang Y; Lin Z; Peng L
Int J Gen Med; 2021; 14():7487-7501. PubMed ID: 34744456
[TBL] [Abstract][Full Text] [Related]
6. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
7. LPCAT1 overexpression promotes the progression of hepatocellular carcinoma.
He RQ; Li JD; Du XF; Dang YW; Yang LJ; Huang ZG; Liu LM; Liao LF; Yang H; Chen G
Cancer Cell Int; 2021 Aug; 21(1):442. PubMed ID: 34419067
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
9. An Integrated Analysis of the Identified PRPF19 as an Onco-immunological Biomarker Encompassing the Tumor Microenvironment, Disease Progression, and Prognoses in Hepatocellular Carcinoma.
Yang M; Qiu Y; Yang Y; Wang W
Front Cell Dev Biol; 2022; 10():840010. PubMed ID: 35252202
[No Abstract] [Full Text] [Related]
10. LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma.
Zhang H; Xu K; Xiang Q; Zhao L; Tan B; Ju P; Lan X; Liu Y; Zhang J; Fu Z; Li C; Wang J; Song J; Xiao Y; Cheng Z; Wang Y; Zhang S; Xiang T
Genes Dis; 2022 Jan; 9(1):151-164. PubMed ID: 35005115
[TBL] [Abstract][Full Text] [Related]
11. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
[TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
13. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
[TBL] [Abstract][Full Text] [Related]
14. The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis.
Zhang C; Ke Y; Lei X; Liu X; Li H; Shi R; Wang L
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33660763
[TBL] [Abstract][Full Text] [Related]
15. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
Shang BB; Chen J; Wang ZG; Liu H
PeerJ; 2021; 9():e12315. PubMed ID: 34754620
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of FAM57A Expression and Its Potential Roles in Hepatocellular Carcinoma.
Wei J; Liu Y; Zhao C
Front Oncol; 2021; 11():719973. PubMed ID: 34790567
[TBL] [Abstract][Full Text] [Related]
17. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
18. ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC.
Yao S; Yin X; Chen T; Chen W; Zuo H; Bi Z; Zhang X; Jing Y; Pang L; Cheng H
Am J Cancer Res; 2021; 11(11):5319-5337. PubMed ID: 34873463
[TBL] [Abstract][Full Text] [Related]
19. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
